Connection

Kathrin Jansen to Child

Back to Details
This is a "connection" page, showing publications Kathrin Jansen has written about Child.
Kathrin Jansen
Connection Strength
0.028
Child
  1. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 07 15; 385(3):239-250.
    View in: PubMed
    Score: 0.007
  2. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents. Vaccine. 2019 03 14; 37(12):1710-1719.
    View in: PubMed
    Score: 0.006
  3. A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. N Engl J Med. 2017 12 14; 377(24):2349-2362.
    View in: PubMed
    Score: 0.006
  4. Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France. Vaccine. 2017 03 13; 35(11):1530-1537.
    View in: PubMed
    Score: 0.005
  5. A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr Infect Dis J. 2013 Apr; 32(4):364-71.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.